Individualized busulfan dosing improves outcomes compared to fixed dose administration in pre‐transplant MRD positive AML patients with intermediate risk undergoing allogeneic stem cell transplantation in CR

European Journal of Haematology(2022)

引用 0|浏览2
暂无评分
关键词
acute myeloid leukemia, allogeneic hematopoietic stem cell transplantation, minimal/measurable residual disease, multiparameter flow cytometry, PK-guided busulfan
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要